Portal de recerca
ESTUDIO DE ADHERENCIA EN TRIPLE TERAPIA PARA LA HEPATITIS C (ESTUDIO ADHOC).
Dades bàsiques
- Protocol:
- IMI-TRI-2013-01
- EURDRACT:
- NCT:
- Centre:
- Any inici:
- Any de finalització:
Documents
- No hi ha documents
Participants
-
Marina Berenguer Haym
Investigador Principal
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
HOW SHOULD I MANAGE HBV IN THE WAITLISTED PATIENT?
MARINA BERENGUER HAYM, J. FUNG
Capítulo de un Libro. 2017
"Posttransplant calcineurin inhibitors levels and intra-patient variability are not associated with long term outcomes following liver transplantation".
Di Maira T; (...); Berenguer M
Article. 10.1097/TP.0000000000002987. 2020
A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.
Penning, Louis C.; (...); Weiskirchen, Ralf
Article. 10.3390/biomedicines11020420. 2023
A multicenter study to assess the incidence of hepatocellular carcinoma recurrence after liver transplantation in patients treated with direct-acting antivirals for chronic hepatitis C
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2018
A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1371/journal.pone.0228351. 2020
Access to liver transplant for women in Spain: a national registry analysis
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Access to liver transplant for women in Spain: a national registry analysis
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach
de la Peña-Moral JM; (...); Parrilla P
Article. 10.1111/hepr.12369. 2015
Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
Andacoglu, Oya; (...); Selzner, Nazia
Article. 10.3389/ti.2023.11240. 2023
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives.
Gitto S; (...); Berenguer M
Editorial Material. 10.1155/2019/8691502. 2019
Alterations in carbohydrate metabolism in cirrhotic patients before and after liver transplant
Ramos-Prol A; (...); Merino-Torres JF
Article. 10.1016/j.diabres.2015.10.002. 2015
An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation
Rodriguez-Peralvarez, M; (...); De la Mata, M
Article. 10.1111/ctr.13005. 2017
Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.
Chadha, Ryan; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004803. 2023
Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
Tejedor, Marta, Selzner, Nazia, Berenguer, Marina
Article. 10.1097/TP.0000000000004163. 2022
ATP7B AND OTHER GENES RESULTING IN WILSON DISEASE (WD) PHENOTYPE
Sanchez-Monteagudo, A; (...); Berenguer, M
Meeting Abstract. 2019
Beyond cure: preventing and managing the complications of end-stage liver disease
Berenguer M; (...); Puoti M
Review. 10.1097/COH.0000000000000184. 2015
Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation
Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2022
Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?
Herreras, J.; (...); Aguilera, V.
Article. 2022
Circulating MicroRNAs: Dynamic Markers of Liver Transplant Injury.
Mas VR, Bardhi E, Berenguer M
Article. 10.1097/TP.0000000000003816. 2021
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
Simao, Andre Lopes; (...); Castro, Rui E
Article. 10.1016/j.jhepr.2023.100697. 2023
Clinical and molecular characterization of Wilson's disease in the Valencian Region
Sanchez-Monteagudo, A; (...); Espinos, C
Meeting Abstract. 2018
CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)
Aguilera, V.; (...); Berenguer, M.
Meeting Abstract. 2023
CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2022
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley KV; (...); Villamil A
Article. 10.14309/ajg.0000000000003029. 2024
Combined Resistance and Endurance Training at a Moderate-to-High Intensity Improves Physical Condition and Quality of Life in Liver Transplant Patients
Moya-Najera, D; (...); Colado, JC
Article. 10.1002/lt.24827. 2017
Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients
Reig, Anna; (...); Pares, Albert
Meeting Abstract. 2020
Computational models of liver fibrosis progression for hepatitis C virus chronic infection
Lara J; (...); Khudyakov YE
Article. 10.1186/1471-2105-15-S8-S5. 2014
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Aller, R; (...); Romero-Gomez, M
Correction. 10.1016/j.gastrohep.2018.05.011. 2018
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Aller, R; (...); Romero-Gomez, M
Review. 10.1016/j.gastrohep.2017.12.003. 2018
Control of Diabetes Mellitus in Liver Transplant Recipients
Ramos-Prol, Agustin; (...); Francisco Merino-Torres, Juan
Article. 2014
Controlling Diabetes After Liver Transplantation: Room for Improvement
Alvarez-Sotomayor D; (...); Berenguer M
Article. 10.1097/TP.0000000000001399. 2016
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley, Kris V; (...); Villamil, Alejandra
Article. 10.14309/ajg.0000000000003153. 2024
Corrigendum to "Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives".
Gitt S; (...); Berenguer M
Correction. 10.1155/2020/4305190. 2020
COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey
Vinaixa, Carmen; (...); Berenguer, Marina
Meeting Abstract. 2022
COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey
Vinaixa, C.; (...); Berenguer, M.
Meeting Abstract. 2022
COVID-19 and liver transplantation
Editorial Material. 10.1038/s41575-020-0347-z. 2020
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel
Meeting Abstract. 2022
Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study
Aguilera, V; (...); Berenguer, M
Article. 10.1111/tri.13145. 2018
Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation
Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel
Meeting Abstract. 2023
CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.
Carvalho-Gomes Â; (...); López-Labrador FX
Article. 10.1016/j.cellimm.2021.104455. 2022
Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation
Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2024
Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain
Hernandez-Evole, H, Briz-Redon, A, Berenguer, M
Article. 10.4254/wjh.v12.i6.277. 2020
Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
Mínguez Sabater A; (...); Berenguer, Marina
Article. 10.1016/j.gastrohep.2021.03.017. 2022
CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM A CLASSICALLY LOW PREVALENCE AREA
Minguez, Alejandro; (...); Berenguer, Marina
Meeting Abstract. 2021
Characteristics and trends of liver transplantation in a cohort of patients with primary sclerosing cholangitis: a retrospective multicenter study
Minguez, A.; (...); Berenguer, M.
Meeting Abstract. 2022
Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)
Di Maira, T; (...); European Liver & Intestine
Meeting Abstract. 2021
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry
Berenguer M; (...); European Liver Intestine Transplan
Article. 10.1097/TP.0000000000003542. 2021
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting
Perricone, G; (...); European Liver Intestine Transpla
Article. 10.1111/liv.13878. 2018
Delisting of Liver Transplant Candidates with Chronic HCV Infection after Viral Erradication: Outcome 2 Years after Delisting. A European Study
Vinaixa, C; (...); Duvuox, C
Meeting Abstract. 10.1097/01.tp.0000542536.91165.49. 2018
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
Belli LS; (...); European Liver and Intestine Association (ELITA)
Article. 10.1016/j.jhep.2016.05.010. 2016
Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study
Belli, LS; (...); Duvoux, C
Meeting Abstract. 10.1016/S0168-8278(17)30339-2. 2017
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024)
De Vincentis, A.; (...); Conde, Isabel
Correction. 2025
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
De Vincentis, Antonio; (...); Carbone, Marco
Article. 10.1016/j.cgh.2024.05.008. 2024
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Correction. 10.1111/ajt.15244. 2019
Disease Reversibility in Patients With Post-Hepatitis C Cirrhosis: Is the Point of No Return the Same Before and After Liver Transplantation? A Review
Vinaixa, C, Strasser, SI, Berenguer, M
Review. 10.1097/TP.0000000000001633. 2017
Distinct features of hepatitis delta in a Mediterranean setting
Hernandez-Evole, H, Berenguer-Haym, M
Meeting Abstract. 10.1016/S0618-8278(19)30486-4. 2019
Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?
Trapero-Marugan, M.; (...); Cuervas-Mons, V.
Meeting Abstract. 2023
Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2023
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: A nationwide multicenter study
Tellez, Luis; (...); Albillos, Agustin
Article. 10.1111/apt.16926. 2022
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
Cortesi, Paolo Angelo; (...); Belli, Luca Saverio
Article. 10.3389/ti.2023.10954. 2023
EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)
Kowdley, Kris V.; (...); Villamil, Alejandra
Meeting Abstract. 2023
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
Forns X; (...); Van Solingen-Ristea R
Article. 2016
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study
Forns, X; (...); Jessner, W
Article. 10.1111/tid.12696. 2017
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.
Forns, Xavier; (...); Jessner, Wolfgang
Article. 2017
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
Crespo, J; (...); Antolin, GS
Article. 10.17235/reed.2019.6700/2019. 2019
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
Crespo J; (...); Sánchez Antolín G
Article. 10.1016/j.gastrohep.2019.09.002. 2019
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients
Belli, LS; (...); Strazzabosco, M
Review. 10.1016/j.jhep.2017.03.006. 2017
ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.
Belli, Luca S; (...); ELITA board members
Guideline. 2017
Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis
Tinguely, Pascale; (...); Spiro, Michael
Article. 10.1111/ctr.14453. 2021
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.
Pollok, Joerg M.; (...); Spiro, Michael
Article. 10.1016/S2468-1253(22)00268-0. 2023
Equally Interchangeable? How Sex and Gender Affect Transplantation
Melk, A; (...); Berenguer, M
Review. 10.1097/TP.0000000000002655. 2019
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.
Cillo U; (...); Selzner N
Review. 10.3389/ti.2022.10915. 2022
European and American Temporal Trends and Outcomes in Liver Transplant (LT) Patients with Human Immunodeficiency Virus (HIV)
Campos-Varela, I; (...); Terrault, N
Meeting Abstract. 2017
European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
Berenguer M; (...); Zubair H
Article. 10.3389/ti.2023.11358. 2023
Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.
Marino, Zoe; (...); Berenguer, Marina
Article. 10.1097/HEP.0000000000001105. 2024
EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP
Mendez, Zoe Marino; (...); Berenguer, Marina
Meeting Abstract. 2024
Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up
Marino, Zoe; (...); Berenguer, Marina
Meeting Abstract. 2024
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management
Jadoul, M; (...); Martin, P
Article. 10.1016/j.kint.2018.06.011. 2018
EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND
Berenguer, Marina; (...); Carbone, Marco
Meeting Abstract. 2021
Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry
Romero-Gutierrez, Marta; (...); Marino, Zoe
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients
Sahuco, Ivan; (...); Berenguer, Marina
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1002/ueg2.12571. 2024
Fat and liver transplantation: clinical implications
Vinaixa, C, Selzner, N, Berenguer, M
Review. 10.1111/tri.13288. 2018
Fat, cancer, the gut-liver axis and rare liver diseases.
Editorial Material. 10.1016/j.jhepr.2020.100189. 2020
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.
Martinez-Arenas, Laura; (...); Berenguer, Marina
Article. 10.1111/liv.16085. 2024
First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Frailty and Sarcopenia in Acute-on-Chronic Liver Failure
Renau, LP; (...); Berenguer M
Article. 10.1002/hep4.1722. 2021
Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1097/TXD.0000000000001599. 2024
Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.1002/lt.24128. 2015
GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE
Andacoglu, Oya; (...); Selzner, Nazia
Meeting Abstract. 2021
Gender and racial discrimination among liver transplantation professionals: report of a global survey
Aguilera, V.; (...); Selzner, N.
Article. 2022
Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey
Aguilera, Victoria; (...); Selzner, Nazia
Article. 10.3389/ti.2022.10506. 2022
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, Isabel; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain.
Sánchez-Monteagudo A; (...); Espinós C
Article. 10.1111/cge.13719. 2020
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)
Calleja, JL; (...); Pineda, JA
Article. 10.1016/j.gastrohep.2018.07.010. 2018
HCV cirrhosis: liver volume as a non-invasive predictor of liver recovery post DAA treatment
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 10.1016/S0168-8278(17)31568-4. 2017
HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans
Bohne, Felix; (...); Sanchez-Fueyo, Alberto
Article. 10.1126/scitranslmed.3008793. 2014
Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.
Marino, Zoe; (...); Anguera, Anna
Article. 10.3390/jcm12144823. 2023
Heat stroke and fulminant hepatitis: Conservative management or liver transplant?
Ladrón Abia P; (...); Berenguer Haym MC
Letter. 10.1016/j.gastrohep.2020.11.004. 2021
Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling
Noon, Luke; (...); Lloyd, Alison
Meeting Abstract. 2023
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
Catala-Senent, Jose F.; (...); Garcia-Garcia, Francisco
Article. 10.1186/s13293-021-00368-1. 2021
Hepatitis C-related cirrhosis: Current status
Conde, I, Vinaixa, C, Berenguer, M
Review. 10.1016/j.medcli.2016.09.019. 2017
HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity
Andrade, Rita; (...); Cardoso, Joana
Article. 10.3390/cancers17030500. 2025
High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain
Crespo J; (...); Hernández-Guerra M
Article. 10.1016/S1665-2681(19)31169-X. 2015
HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study
Vinaixa, C.; (...); Prieto, M.
Meeting Abstract. 2019
HIV Infection Is Not Associated with Increased Cardiovascular Risk in Liver Transplant Recipients: A Single Center Comparative Study
Herreras, J; (...); Berenguer, M
Meeting Abstract. 2018
Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation
Sáez-González E; (...); Berenguer M
Letter. 10.1038/ajg.2016.260. 2016
Immunosuppression in liver transplant.
Di Maira T, Little EC, Berenguer M
Review. 10.1016/j.bpg.2020.101681. 2020
IMPACT OF ANTICOAGULANT THERAPY ON UPPER GASTROINTESTINAL BLEEDING (UGI) IN PATIENTS WITH LIVER CIRRHOSIS. RESULTS FROM A RETROSPECTIVE MULTICENTRIC CASE-CONTROL STUDY
Cerini, F.; (...); Garcia-Pagan, J. C.
Article. 10.1016/S0168-8278(14)60019-2. 2014
Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study
Cerini F; (...); Garcia-Pagán JC
Article. 10.1002/hep.27783. 2015
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper.
Marjot, Thomas; (...); Cornberg, Markus
Article. 10.1016/j.jhep.2022.07.008. 2022
Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)
Saez-Gonzalez, E; (...); Berenguer, M
Article. 10.1111/liv.13618. 2018
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend R.; (...); IJzermans, Jan N. M.
Article. 10.1002/jcsm.13053. 2022
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend; (...); Ijzermans, Jan
Meeting Abstract. 10.1002/jcsm.13053. 2022
Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study
Marino, Zoe; (...); Anguera, Anna
Meeting Abstract. 2023
Incidence and prognostic impact of cancer after liver transplantation
Gastaca, M; (...); Rodriguez-Peralvarez, M
Meeting Abstract. 2021
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2023
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera
Meeting Abstract. 2023
Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years
Ramos-Prol, A.; (...); Merino-Torres, J. F.
Article. 10.1007/s40618-017-0810-z. 2018
International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation
Tsochatzis, E; (...); Berenguer, M
Review. 10.1097/TP.0000000000002433. 2019
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates
Terrault, NA; (...); Berenguer, M
Review. 10.1097/TP.0000000000001708. 2017
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients
Terrault, NA; (...); McCaughan, GW
Review. 10.1097/TP.0000000000001704. 2017
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients
Charlton, M; (...); Saliba, F
Review. 10.1097/TP.0000000000002147. 2018
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients (vol 102, pg 727, 2018)
Correction. 10.1097/TP.0000000000002535. 2019
International Liver Transplantation Society Global Census report: a first look at the pediatric liver transplantation activity around the world
Lopez-Verdugo, F; (...); Pediat Liver Transplantation
Meeting Abstract. 2021
International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies
Puchades Renau, L, Berenguer, M
Review. 10.1111/hdi.12647. 2018
Kinetics of Cytomegalovirus Specific Polyfunctional T-Cell Responses Associated with Control of CMV Reactivation after Liver Transplantation.
Carvalho-Gomes, A; (...); Lopez-Labrador, FX
Meeting Abstract. 2018
Lack of effect of CMV reactivation in the outcome of HCV-infected liver transplant(LT)patients
Aguilera, Victoria; (...); Berenguer, Marina
Article. 2015
Last Gasps of the Hepatitis C Virus Dragon: Direct Acting Antiviral Failures and Hepatitis C Virus-Positive Donors
Article. 10.1002/lt.24520. 2016
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Launch of the International Living Donor Liver Transplantation Outcomes Registry.
Staubli, Sebastian; (...); Rela, Mohamed
Letter. 10.1016/S2468-1253(23)00185-1. 2023
Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice
Crespo J; (...); Calleja JL
Article. 10.1016/j.gastrohep.2015.04.002. 2015
Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Liver Transplantation 2023: Status Report, Current and Future Challenges.
Terrault, Norah A; (...); Heimbach, Julie
Article. 10.1016/j.cgh.2023.04.005. 2023
Liver Transplantation for Alcoholic Liver Disease
Addolorato G; (...); Berenguer M
Review. 10.1097/TP.0000000000001156. 2016
LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: LOW PREVALENCE REGIONS ARE CATCHING UP
Martinez Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)
Belli, LS; (...); ELITA EF-CLIF Working Grp
Article. 10.1016/j.jhep.2021.03.030. 2021
Liver volume as a predictor of functional improvement post DAA treatment
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2017
Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment
Di Maira, T; (...); Berenguer, M
Article. 10.1097/TP.0000000000001990. 2018
Liver Volume as a Predictor of Outcome after HCV Eradication in Cirrhotic Patients
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2017
LOCATION AND ALLOCATION: INEQUITY OF ACCESS TO LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE GRADE 3 (ACLF-3) ACROSS EUROPE.
Artzner, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2021
Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe.
Artzner, Thierry; (...); Jalan, Rajiv
Article. 10.1002/lt.26499. 2022
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.
Gomez, E; (...); Fernandez-Rodriguez, C M
Article. 10.1111/apt.18004. 2024
Long-Term Complications After Liver Transplantation: Results at 15 Years After Transplantation
Berenguer, Marina; (...); Prieto, Martn
Article. 2015
Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.
Legendre C; (...); Guthoff M
Article. 10.1097/TP.0000000000002316. 2018
Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
Heinemann M; (...); all the other contributing centers (www.eltr.org) and the European Liver and Int
Article. 10.1111/ajt.16864. 2022
Long-term outcomes of the octogenarian donor liver recipient: The era of the new centurion.
Schneider S; (...); Berenguer M
Article. 10.1111/ctr.13629. 2019
Long-term patient and graft survival after liver transplantation for autoimmune hepatitis
Heinemann, Melina; (...); Schramm, Christoph
Meeting Abstract. 2020
Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Long-term survival after liver transplantation for autoimmune hepatitis - results from the European Liver Transplant Registry.
Heinemann M; (...); Schramm C
Article. 10.1002/lt.25739. 2020
Long-term survival after living donor liver transplantation in primary sclerosing cholangitis
Liwinski, T; (...); Schramm, C
Meeting Abstract. 2021
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis
Article. 10.1016/j.dld.2024.09.002. 2024
Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry
Marino, Zoe; (...); Castillo, Pilar
Meeting Abstract. 2023
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.
Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria
Article. 10.1016/j.trre.2024.100875. 2024
Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kirchner, Varvara A.; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004771. 2023
Management of HCV in the liver transplant setting
Review. 10.1016/j.clinre.2015.05.004. 2015
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation.
Herreras J; (...); Berenguer M
Article. 10.1097/TXD.0000000000000934. 2019
Mitochondrial bioenergetics boost macrophages activation promoting liver regeneration in metabolically compromised animals.
Goikoetxea-Usandizaga, Naroa; (...); Martínez-Chantar ML
Article. 10.1002/hep.32149. 2021
MORE THAN A THIRD OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA HAVE A DECREASE OR REACH UNDETECTABLE LEVELS OF HDV-RNA DURING NATURAL HISTORY
Palom, A; (...); Ferret, MAB
Meeting Abstract. 2020
Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.
Serrano MT; (...); Salcedo M
Article. 10.3389/ti.2022.10263. 2022
Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease
Bruguera M; (...); Mariño Z
Editorial Material. 10.1016/j.gastrohep.2016.06.003. 2016
Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease (vol 39, pg 571, 2016)
Bruguera, M; (...); Mariño Z
Correction. 10.1016/j.gastrohep.2017.02.005. 2017
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors
Martin-Mateos, R.; (...); Albillos, A.
Meeting Abstract. 2024
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP; (...); Sweeney C
Article. 10.1016/j.euo.2024.03.010. 2024
New ERAS in liver transplantation - Past, present, and next steps
Hannon, Vivienne N.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14625. 2022
Non-alcoholic steatohepatitis as liver transplant indication: similarities and differences between a high and a low prevalence countries
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Non-alcoholic steatohepatitis is also becoming a major liver transplant indication in Spain, a historically low risk area
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes
Review. 10.51821/86.2.11430. 2023
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
Reig, A; (...); Pares, A
Article. 10.14309/ajg.0000000000001343. 2021
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
Hézode C; (...); Pol S
Article. 10.1016/S0140-6736(15)60159-3. 2015
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
Hezode, Christophe; (...); Pol, Stanislas
Article. 2015
Ombitasvir/Paritaprevir/r and Dasabuvir with or without Ribavirin for HCV Patients with Post-Transplant Recurrence
Mantry, Parvez S.; (...); Forns, Xavier
Article. 2015
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia
Forns X; (...); Everson G
Article. 10.1111/liv.12931. 2015
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
Palom, A; (...); Buti, M
Article. 10.1111/apt.16485. 2021
ON-TREATMENT VIROLOGIC RESPONSE AND TOLERABILITY OF SIMEPREVIR, DACLATASVIR AND RIBAVIRIN IN PATIENTS WITH RECURRENT HEPATITIS C VIRUS GENOTYPE 1b INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLT): INTERIM DATA FROM THE PHASE II SATURN STUDY
Forns, X.; (...); Witek, J.
Article. 10.1016/S0168-8278(15)30011-8. 2015
Optimal management of perioperative analgesia regarding immediate and short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert panel recommendations
Sun, Li-Ying; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14640. 2022
Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry
Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena
Meeting Abstract. 2024
Out of Milan criteria and worse intetion to treat results at large liver transplant center
Lopez, JH; (...); Haym, MB
Meeting Abstract. 10.1016/S0168-8278(18)30613-5. 2018
Outcome of liver transplant candidates "delisted" after successful treatment of HCV infection
Perricone, G; (...); ELITA
Meeting Abstract. 2018
Outcomes in liver transplantation: Does sex matter?
Sarkar M; (...); Berenguer M
Review. 10.1016/j.jhep.2014.11.023. 2015
Out-of-Milan criteria and worse intention-to-treat results at a large liver transplant (LT) centre
Herreras, J; (...); Berenguer, M
Meeting Abstract. 2018
Out-of-Milan HCC criteria and worse intention-to-treat results following liver transplantation
Herreras, J.; (...); Berenguer, M.
Meeting Abstract. 2019
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Overcoming drug resistance in HSV, CMV, HBV and HCV infection
López-Labrador FX, Berenguer M, Navarro D
Review. 10.2217/fmb.15.74. 2015
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.
Marques, Patrice; (...); Sanz, Maria-Jesus
Article. 10.3390/ijms24032313. 2023
Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
Pilar Ballester, Maria; (...); Nicastro, Emanuele
Meeting Abstract. 2024
Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance
Pallares, C; (...); Lopez-Labrador, FX
Article. 10.1016/j.jcv.2018.02.016. 2018
Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
Vinaixa, C; (...); Prieto, M
Letter. 10.1002/lt.25297. 2018
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
Editorial Material. 10.5604/16652681.1235470. 2017
PHYSICAL FRAILTY IN LIVER TRANSPLANTATION.
Puchades Renau L; (...); Berenguer Haym M
Review. 10.17235/reed.2020.7448/2020. 2021
Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infection
Pallares, C; (...); Berenguer, M
Meeting Abstract. 10.1016/S0168-8278(17)31165-0. 2017
Population screening using a point-of-care test reveals unexpectedly low prevalence of active HCV infection in Spain
Carvalho-Gomes, A; (...); Berenguer, M
Meeting Abstract. 2017
Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kow, Alfred Wei Chieh; (...); Ikegami, Toru
Article. 10.1097/TP.0000000000004770. 2023
Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
Berenguer, M; (...); van der Laan, LJW
Review. 10.1097/TP.0000000000003196. 2020
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; (...); Berenguer M
Article. 10.1016/j.aohep.2019.06.014. 2019
PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)
De Vincentis, Antonio; (...); Carbone, Marco
Meeting Abstract. 2023
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Ampuero J; (...); Fernández-Rodríguez C
Article. 10.1097/HEP.0000000000000826. 2024
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence
Song AT; (...); Samuel D
Article. 10.3748/wjg.v22.i18.4547. 2016
Predictive factors of response to corticosteroid therapy in acute severe autoinmune hepatitis: a national multicentric study
Sanchez Rodriguez, Eugenia; (...); Albillos, Agustin
Meeting Abstract. 2020
Pregnancy and autoimmune hepatitis: presentation and outcomes
Llovet, LP; (...); Londono, MC
Meeting Abstract. 10.1016/S0168-8278(18)30683-4. 2018
Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.
Llovet LP; (...); Londoño MC
Letter. 10.1016/j.cgh.2018.12.030. 2019
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Hakeem AR; (...); Rela M
Article. 10.1097/TP.0000000000004769. 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel
Article. 10.7326/M23-2391. 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
Gordon, CE; (...); Martin, P
Article. 10.7326/M19-1539. 2019
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
Ampuero J; (...); Molina E
Letter. 10.1136/gutjnl-2021-325700. 2021
Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment
Pares, A; (...); Gil, A
Article. 10.17235/reed.2018.5665/2018. 2018
Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology
Fernandez, Ainhoa; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.
Minguez, Alejandro; (...); Berenguer, Marina
Article. 10.1007/s10620-024-08368-y. 2024
Profile of plasma microRNAs as a potential biomarker of Wilson's disease.
Sanchez-Monteagudo, Ana; (...); Espinos, Carmen
Article. 10.1007/s00535-024-02135-6. 2024
Profiles and clinical management of hepatitis C patients in Spain: disHCovery study
Buti M; (...); Esteban R
Article. 2015
Profiles and clinical management of hepatitis C patients in Spain: disHCovery study (vol 28, pg 145, 2015)
Buti, Maria; (...); Esteban, Rafael
Article. 2015
Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict
Silva, Silvia Gomes; (...); Cardoso, Joana
Meeting Abstract. 2024
Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org
Turner, B.; (...); Salinas, C. Hidalgo
Meeting Abstract. 2023
Pushing the donor limits: Deceased donor liver transplantation using organs from octogenarian donors
Díaz Jaime F, Berenguer, M
Article. 10.1002/lt.24841. 2017
Re: Tacrolimus Trough Concentrations after Liver Transplantation: .
Di Maira T; (...); Berenguer M
Letter. 10.1097/TP.0000000000003087. 2020
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.
Crespo, Javier; (...); Calleja, Jose Luis
Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Remnant vital tissue following locoregional therapy for hepatocellular carcinoma: another player in the game
Editorial Material. 10.1111/tri.13274. 2018
Reply to: "Renal impairment and anemia during triple therapy"
Romero-Gómez M; (...); Calleja JL
Letter. 10.1016/j.jhep.2014.01.007. 2014
Reproductive and pregnancy control in Wilson disease patients in Spain.
Romero-Gutiérrez M; (...); Mariño Z
Article. 10.1097/MEG.0000000000002831. 2024
Reversion of disease manifestations after HCV eradication
van der Meer AJ, Berenguer M
Review. 10.1016/j.jhep.2016.07.039. 2016
Rising indication of non-alcoholic steatohepatitis as transplant indication in historically low risk areas
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
Lucena, Ana; (...); Ampuero, Javier
Meeting Abstract. 2023
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Safety and Efficacy of Interferon-free Antiviral Treatment in Patients with MELD over 20
Vinaixa, C; (...); Berenguer, M
Meeting Abstract. 2017
Safety and efficacy of ombitasvir/paritaprevir/ritonavir +/- dasabuvir and +/- ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3-6)
Agarwal, K; (...); Forns, X
Meeting Abstract. 10.1016/S0168-8278(17)31461-7. 2017
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Mehta, Gautam; (...); Jalan, Rajiv
Article. 10.1097/HC9.0000000000000273. 2023
Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?
Selzner, N, Berenguer, M
Article. 10.1002/lt.25072. 2018
Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry
Diaz-Gonzalez, Alvaro; (...); del Registro, Grupo
Meeting Abstract. 2022
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study
Berenguer, Marina; (...); GEMHEP
Article. 10.1016/j.gastrohep.2022.10.018. 2023
Significant heterogeneity in the diagnosis and management of Wilson Disease (WD): results from a large Spanish Registry.
Meeting Abstract. 2017
Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.
Berenguer, M, de la Rosa Rodríguez G, Dominguez-Gil, B
Letter. 10.1016/j.jhep.2018.06.011. 2018
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Simple score to assess cardiovascular risk post-liver transplantation
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2021
SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION
Di Maira, Tommaso; (...); Berenguer, Marina
Meeting Abstract. 2022
Stretching the boundaries for liver transplant in the 21st century
Trapero-Marugan, M, Little, EC, Berenguer, M
Review. 10.1016/S2468-1253(18)30213-9. 2018
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?
Cabezas, Joaquin; (...); Crespo Garcia, Javier
Meeting Abstract. 2023
Temporal Trends and Outcomes in Liver Transplantation for Recipients with Human Immunodeficiency Virus Infection in Europe and United States.
Campos-Varela I; (...); Terrault NA
Article. 10.1097/TP.0000000000003107. 2019
The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D
Palom, Adriana; (...); Buti, Maria
Meeting Abstract. 2024
The Era of the New Centurion: Long Term Outcomes of the Octogenarian Liver
Diaz, FC; (...); Berenguer, M
Meeting Abstract. 2017
The first fifteen days of calcineurin inhibitors exposure do not predict post-transplant malignant outcomes
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2018
The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
The ILTS Consensus Conference on NAFLD/NASH and Liver Transplantation: Setting the Stage
Burra, P, Berenguer, M, Pomfret, E
Article. 10.1097/TP.0000000000002507. 2019
The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way.
Colmenero J, Berenguer M, Watt KD
Article. 10.1097/TP.0000000000003994. 2022
The impact of COVID-19 on liver transplant (LT) centers across the world during the first wave: a Multisociety Survey (EASL-ESOT/ELITA-ILTS)
Russo, FP; (...); Polak, W
Meeting Abstract. 2021
THE IMPACT OF DIRECT ACTING ANTIVIRALS ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC RETROSPECTIVE STUDY
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2019
The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study
Gorgen, A; (...); Sapisochin, G
Article. 10.1097/TP.0000000000003115. 2020
The New Era of Hepatitis C Therapy in Liver Transplant Recipients
Little, EC, Berenguer, M
Article. 10.1016/j.cld.2016.12.012. 2017
THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION
Herreras, J; (...); Aguilera, V
Meeting Abstract. 2021
The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.
Domínguez-Gil B; (...); Delmonico FL
Article. 10.1097/TP.0000000000004186. 2022
The road map toward an hepatitis C virus-free transplant population.
Berenguer, M; (...); Samuel, D
Article. 10.1111/ajt.14976. 2018
The role of early extubation on short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert recommendations
Tinguely, Pascale; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14642. 2022
The role of preoperative optimization of the nutritional status on the improvement of short-term outcomes after liver transplantation? A review of the literature and expert panel recommendations
Victor, David W.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14647. 2022
Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry
Berenguer, Marina; (...); Marino, Zoe
Meeting Abstract. 2024
Transplant Oncology in Primary and Metastatic Liver Tumor: Principles, Evidence and Opportunities.
Sapisochin G; (...); Mazzaferro V
Article. 10.1097/SLA.0000000000004071. 2020
Transplantation: A Priority in the Healthcare Agenda.
Muller E; (...); Potena L
Article. 10.1097/TP.0000000000005182. 2025
Tratamiento de la hepatitis C en grupos de pacientes especiales.
Berenguer M; (...); Castellano G
Abstract of Published Item. 10.1016/S0210-5705(15)30004-2. 2014
TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY
Forns, X.; (...); Bertelsen, K.
Article. 2014
Trends in liver transplantation for acute liver failure. A Spanish multicenter study
Conde, Isabel; (...); Berenguer, Marina
Meeting Abstract. 2022
Trends in liver transplantation for acute liver failure: a Spanish multicenter study
Conde, I.; (...); Berenguer, M.
Meeting Abstract. 2022
Triple Therapy for HCV Cirrhosis in Liver Transplant Candidates. High Rate of Prevention of HCV Recurrence after Liver Transplantation (LT) in Well Selected Patients
Maria Braithwaite, Ana; (...); Berenguer, Marina
Article. 2014
Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey
Vinaixa, C.; (...); Terrault, N.
Meeting Abstract. 2024
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
Vinaixa, Carmen; (...); Berenguer, Marina
Article. 10.1097/LVT.0000000000000432. 2024
Validation of MELD3.0 in 2 centers from different continents.
Tejedor M; (...); Berenguer M
Article. 10.1097/HC9.0000000000000504. 2024
Validation of MELD3.0 in two centres from different continents
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Validation of MELD3.0 in two centres from different continents
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry
Kantsedikas, Ilya; (...); Rela, Mohamed
Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024
Very early immunosuppression predicts the first-year renal function post liver transplantation
Di Maira, T.; (...); Berenguer, M.
Meeting Abstract. 2019
Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications
Garcia Garcia, S.; (...); Aguilera, V.
Meeting Abstract. 2023
Waiting time dictates impact of frailty: A Spanish multicenter prospective study.
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1016/j.jhepr.2023.100840. 2023
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations
Kirchner, Varvara A.; (...); ERAS4OLT Org Working Grp
Review. 2022
Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study
Belli, Luca Saverio; (...); Arroyo, Vicente
Meeting Abstract. 2020
Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease
Sánchez-Monteagudo A; (...); Espinós C
Review. 10.3390/biomedicines9091100. 2021
Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry
Tejedor, Marta; (...); Berenguer, Marina
Meeting Abstract. 2024
Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.
Tejedor, Marta; (...); Berenguer, Marina
Article. 10.3389/ti.2024.12732. 2024
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.3389/frtra.2023.1332616. 2023
Análisis De Supervivencia De Pacientes Obesos Sometidos A Trasplante Hepático
Tesis Doctoral
Director/s: MARINA BERENGUER HAYM
El Impacto De La Inmunosupresión Precoz En Las Complicaciones No Asociadas Al Injerto Hepático
Autor/es: Tommaso Di Maira
Tesis Doctoral
Director/s: MARINA BERENGUER HAYM
Estudio Morfometrico Del Estadio De Fibrosis Hepática En El Injerto Hepático De Pacientes Con Hepatitis C Reurrente Post-Trasplante
Tesis Doctoral
Director/s: MARINA BERENGUER HAYM